Benjamin P. Linas, MD

Associate Professor, Medicine

Benjamin Linas
617.414.5238

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Other Positions

  • Associate Professor, Epidemiology, Boston University School of Public Health

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

Publications

  • Published on 7/1/2018

    Linas BP. Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction. 2018 Jul; 113(7):1274-1275. PMID: 29883035.

    Read at: PubMed
  • Published on 6/1/2018

    Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort. AIDS. 2018 Jun 01; 32(9):1125-1135. PMID: 29746317.

    Read at: PubMed
  • Published on 6/1/2018

    Linas BP, Nolen S. A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am. 2018 Jun; 32(2):447-459. PMID: 29778265.

    Read at: PubMed
  • Published on 5/31/2018

    Schechter-Perkins EM, Miller NS, Hall J, Hartman JJ, Dorfman D, Andry C, Linas B. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-Out Hepatitis C Virus Screening Program. Acad Emerg Med. 2018 May 31. PMID: 29851238.

    Read at: PubMed
  • Published on 5/1/2018

    Rodriguez CV, Rubenstein KB, Linas B, Hu H, Horberg M. Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care. 2018 May 01; 24(5):e134-e140. PMID: 29851444.

    Read at: PubMed
  • Published on 4/1/2018

    Saag LA, LaValley MP, Hochberg NS, Cegielski JP, Pleskunas JA, Linas BP, Horsburgh CR. Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018 Apr 01; 22(4):358-365. PMID: 29562981.

    Read at: PubMed
  • Published on 4/1/2018

    Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):405-412. PMID: 29239900.

    Read at: PubMed
  • Published on 3/20/2018

    Murphy SM, Leff JA, Linas BP, Morgan JR, McCollister K, Schackman BR. Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned. Subst Abus. 2018 Mar 20; 1-19. PMID: 29558284.

    Read at: PubMed
  • Published on 3/15/2018

    Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort. AIDS. 2018 Mar 15. PMID: 29547443.

    Read at: PubMed
  • Published on 2/21/2018

    Schackman BR, Gutkind S, Morgan JR, Leff JA, Behrends CN, Delucchi KL, McKnight C, Perlman DC, Masson CL, Linas BP. Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend. 2018 04 01; 185:411-420. PMID: 29477574.

    Read at: PubMed

View 55 more publications: View full profile at BUMC

View all profiles